Zobrazeno 1 - 10
of 5 170
pro vyhledávání: ''
Publikováno v:
European Journal of Surgical Oncology. 48:666-671
Background Oophorectomy is a common procedure in women with peritoneal metastasis (PM) undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), which has unique consequences on hormonal balance and fertility befor
Publikováno v:
European Journal of Surgical Oncology. 47:2865-2872
Introduction Neoadjuvant chemotherapy is widely used in treatment of peritoneal metastases from colorectal cancer, but there is little scientific evidence for this approach. This study aimed to study survival in patients treated with direct surgery w
Autor:
Jennifer Noeller, Mark C. Smith, Patrick W. Hitchon, Brian J. Park, Hesham Yasin, Scott C. Seaman, David Hasan
Publikováno v:
World Neurosurgery. 154:e398-e405
Background Renal cell carcinoma with metastases to the spine (RCCMS) requires a multidisciplinary approach. We reviewed our institutional experience with RCCMS patients undergoing spinal surgery in order to identify factors that may affect clinical o
Autor:
Dan Jian, Dong Wang, Bo Yang, Chunxue Li, Chuan Chen, Wenjun Meng, Bin Huang, Jianwu Zhu, Li Zhong, Lian Bai
Publikováno v:
Journal of Surgical Oncology. 124:1451-1458
To analyze and evaluate the impact of preoperative transcatheter rectal arterial chemoembolization (TRACE) with concurrent chemoradiotherapy on surgery and prognosis of locally advanced rectal cancer (LARC).A total of 118 patients with LARC were enro
Autor:
Norbert Schmitz, Sarah Bergmann, Klaus Wethmar, Rolf M. Mesters, Torsten Keßler, Matthias Stelljes, Wolfgang E. Berdel, Georg Lenz, Ramona Wullenkord, Christoph Schliemann, Mathias Lutz, Philipp Berning, Anna-Lena Niemann
Publikováno v:
Annals of Hematology
Patients with high-risk or relapsed aggressive B-cell lymphomas are characterized by poor prognosis. High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) can induce durable remissions in these patients and is potentially cur
Autor:
Will Baker, Sandy Jack, Malcolm A. West, Timothy J. Underwood, Alicia Munro, Michael P.W. Grocott, Saqib Rahman, Denny Z. H. Levett
Publikováno v:
Journal of Surgical Oncology. 124:1306-1316
Background: Sarcopenia (low skeletal muscle mass), myosteatosis (low skeletal muscle radiation-attenuation) and fitness are independently associated with postoperative outcomes in oesophago-gastric cancer. This study aimed to investigate (1) the effe
Autor:
Shannon Hancher-Hodges, Morgan L. Bruno, Jonathan A. Wilks, Ching Wei D. Tzeng, Jose M. Soliz, Timothy E. Newhook, Matthew H.G. Katz, Naruhiko Ikoma, Jessica E. Maxwell, Jeffrey E. Lee, Elsa M. Arvide, B. Bryce Speer, Whitney L. Dewhurst, Laura R. Prakash, Michael P. Kim
Publikováno v:
Journal of Surgical Oncology. 124:1381-1389
BACKGROUND AND OBJECTIVES The impact of perioperative blood transfusion (PBT) on outcomes for pancreatic ductal adenocarcinoma (PDAC) patients given multimodality therapy (MMT) remains undefined. We sought to evaluate the association of PBT with surv
Autor:
Kabir Mody, Tanios Bekaii-Saab, Thorvardur R. Halfdanarson, Rondell P. Graham, Robert R. McWilliams, Amit Mahipal, Alex J. Liu, M. Bassam Sonbol, Benjamin E. Ueberroth, Mark J. Truty
Publikováno v:
Pancreas. 50:952-956
Objectives This study sought to better characterize patient characteristics, treatment options, and outcomes for osteoclast-like giant cell carcinoma of the pancreas, a rare subtype of pancreatic adenocarcinoma. Methods This is a retrospective study
Autor:
Rafal Tarnawski, Łukasz Magrowski, Andrzej Tukiendorf, Oliwia Masri, Marcin Miszczyk, Elżbieta Nowicka
Publikováno v:
Journal of Clinical Neuroscience. 90:39-47
The optimal timing of adjuvant radiochemotherapy (RCT) in glioblastoma (GBM) patients remains unknown and the paradigm of ‘the sooner, the better’ has been challenged by many recent publications. In this study, we present unique data on the outco
Autor:
Alessandro Paniccia, Nathan Bahary, David L Bartlett, Kenneth K. Lee, Kenneth J. Smith, Amer H. Zureikat, Caroline J. Rieser, Sowmya Narayanan
Publikováno v:
J Surg Oncol
INTRODUCTION: Neoadjuvant therapy (NAT) is an emerging strategy for operable pancreatic ductal adenocarcinoma (PDAC). While neoadjuvant therapy increases multimodal therapy completion, it risks functional decline and treatment drop out. We used decis